Improving Outcomes in Autoimmune Hemolytic Anemias: What the Oncologist Needs to Know.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 8, p. 346
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2023 AND VI 37 AND IP 8
Results: 14
1
2
HER3-DXd Yields Positive Efficacy/Safety Profile in Breast Cancer.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 8, p. 345
- Publication type:
- Article
3
Ribociclib/Endocrine Therapy Improves iDFS in HR+/HER2-- Breast Cancer.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 8, p. 345
- Publication type:
- Article
4
Abemaciclib Combo Maintains Efficacy in Older HER2-- Breast Cancer Population.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 8, p. 345
- Publication type:
- Article
5
Sacituzumab Govitecan Yields Enduring Survival in HR+, HER2-- Breast Cancer.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 8, p. 344
- Publication type:
- Article
6
Axi-Cel Improves Survival vs SOC in Relapsed/Refractory Large B-Cell Lymphoma.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 8, p. 344
- Publication type:
- Article
7
Teclistamab/Talquetamab Appears Tolerable in R/R Multiple Myeloma.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 8, p. 343
- Publication type:
- Article
8
Luspatercept Meets Primary End Point of Transfusion Independence in Myelodysplastic Syndrome.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 8, p. 343
- Publication type:
- Article
9
Brexu-cel Demonstrates Real-World Effi cacy in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 8, p. 343
- Publication type:
- Article
10
Amivantamab vs Mobocertinib in Exon 20 NSCLC.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 8, p. 340
- By:
- Publication type:
- Article
11
Unusual Initial Presentation of Hepatocellular Carcinoma as a Clavicular Head Mass.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 8, p. 335, doi. 10.46883/25921003
- By:
- Publication type:
- Article
12
A Word from Study Author Avyakta Kallam, MD.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 8, p. 330
- By:
- Publication type:
- Article
13
Current Treatments in Mantle Cell Lymphoma.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 8, p. 326, doi. 10.46883/25921002
- By:
- Publication type:
- Article
14
Drug Shortages: What Can Be Done to Alleviate Them?
- Published in:
- Oncology (08909091), 2023, v. 37, n. 8, p. 325
- By:
- Publication type:
- Article